BlackBarn Capital Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.6M | Hold |
1,050,000
| – | – | 1.01% | 6 |
|
|
2025
Q1 | $16.1M | Hold |
1,050,000
| – | – | 1.03% | 7 |
|
|
2024
Q4 | $23.1M | Buy |
1,050,000
+543,029
| +107% | +$12M | 1.27% | 4 |
|
|
2024
Q3 | $9.14M | Buy |
506,971
+6,971
| +1% | +$126K | 1.2% | 11 |
|
|
2024
Q2 | $8.13M | Hold |
500,000
| – | – | 0.72% | 13 |
|
|
2024
Q1 | $7.06M | Buy |
+500,000
| New | +$7.06M | 3.99% | 11 |
|